Drug intelligence / Profile preview

PIMT siRNA

Development stage
Preclinical
Lead developer
UQAM
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intraperitoneal
01

Overview

PIMT siRNA is a small interfering RNA (siRNA) designed to silence the expression of the enzyme protein L-isoaspartyl (D-aspartyl) methyltransferase (PIMT), also known as PCMT1. PIMT is a protein repair enzyme that converts abnormal L-isoaspartyl residues back into normal L-aspartyl residues, and it is found at high levels in the brain. Research, particularly in glioblastoma models like U87-MG cells, has demonstrated that PIMT expression is upregulated when cells detach from the extracellular matrix and that it possesses pro-angiogenic properties. By utilizing siRNA to knock down PIMT, researchers have observed a significant reduction in glioblastoma cell migration and invasion in various assays, including wound healing and Matrigel invasion assays. This suggests that PIMT's catalytic activity is a critical factor in the invasive potential of malignant glioma cells, making it a potential therapeutic target for glioblastoma growth inhibition.

Other names
protein L-isoaspartyl methyltransferase siRNAPCMT1 siRNAPCMT-1 siRNAPCMT 1 siRNAprotein L-isoaspartyl (D-aspartyl) methyltransferase siRNA
02

Targets

Protein-L-isoaspartyl methyltransferase 1 (PCMT1) mRNA

Beyond the preview

Go deeper on PIMT siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIMT siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call